Connection

Chih-Cheng Lai to Angiotensin-Converting Enzyme Inhibitors

Back to Details
This is a "connection" page, showing publications Chih-Cheng Lai has written about Angiotensin-Converting Enzyme Inhibitors.
Chih-Cheng Lai
Connection Strength
0.411
Angiotensin-Converting Enzyme Inhibitors
  1. Risk of Sepsis and Mortality Among Patients With Chronic Obstructive Pulmonary Disease Treated With Angiotensin-Converting Enzyme Inhibitors or Angiotensin Receptor Blockers. Crit Care Med. 2019 01; 47(1):e14-e20.
    View in: PubMed
    Score: 0.211
  2. Comparative effects of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers on the risk of pneumonia and severe exacerbations in patients with COPD. Int J Chron Obstruct Pulmon Dis. 2018; 13:867-874.
    View in: PubMed
    Score: 0.200
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.